GRINX | VTSMX | GRINX / VTSMX | |
Total Expense Ratio | 1.36 | 0.14 | 971% |
Annual Report Gross Expense Ratio | 1.36 | 0.14 | 971% |
Fund Existence | 26 years | 33 years | - |
Gain YTD | 2.214 | 0.817 | 271% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 325M | 1.82T | 0% |
Annual Yield % from dividends | 0.00 | 1.18 | - |
Returns for 1 year | 2.31 | 10.96 | 21% |
Returns for 3 years | 9.11 | 40.34 | 23% |
Returns for 5 years | 30.88 | 80.94 | 38% |
Returns for 10 years | 6.43 | 179.94 | 4% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTIX | 28.77 | N/A | N/A |
Fidelity Advisor Biotechnology I | |||
FEYIX | 27.80 | N/A | N/A |
Fidelity Advisor Asset Manager 85% I | |||
MNHRX | 25.79 | N/A | N/A |
Manning & Napier Pro-Blend Max Term R | |||
FWMNX | 17.06 | N/A | N/A |
Fidelity Advisor Women's Leadership I | |||
EEMHX | 8.78 | N/A | N/A |
MFS Emerging Markets Equity Research R6 |